Noom Adds Oral Weight Loss Medication to Its Offerings with Metformin
Noom expands its Med program to include Metformin, offering a cost-effective oral weight loss option. Learn how this FDA-approved medication, paired with Noom’s behavior change tools, supports sustainable weight management.
75% of Americans Think About Their Weight Daily: What the Data Tells Us
Explore key insights from the 2024 Shape of America Report, revealing how weight impacts health, finances, and daily life. Learn why 75% of Americans think about their weight daily and how trends are shaping wellness in 2025.
Ozempic and Other GLP-1 Agonists May Cut Cancer Risk in Obese Patients, Study Finds
Discover how Ozempic and other GLP-1 agonists may reduce the risk of obesity-associated cancers in a recent study of obese patients. Learn more about the potential cancer-preventive effects of these diabetes medications.
Ro Launches GLP-1 Supply Tracker Amid Rising Demand for Weight Loss Drugs
Discover Ro's new GLP-1 Supply Tracker, providing real-time insights into GLP-1 drug shortages. Learn how this tool helps manage medication availability as demand for weight loss drugs rises.
Active Lifestyles Alter How the Body Burns Saturated Fat, New Study Finds
New research from the University of Aberdeen reveals how physical fitness influences the body's metabolism of saturated fat. Discover how exercise impacts fat utilization and improves overall metabolic health.
The Cost of Discontinuing GLP-1s: Mitigating Financial Impact
Discover strategies to mitigate the high costs of discontinuing GLP-1 medications. Learn how employers can plan for effective weight management and ensure long-term adherence.
Canada Gains Access to Wegovy®, a New Treatment Option for Obesity
Discover the latest breakthrough in obesity treatment as Novo Nordisk launches Wegovy® in Canada on May 6, 2024. Learn how this once-weekly injection can transform obesity management and support millions of Canadians. Explore the effectiveness, safety data, and patient eligibility for Wegovy®.
Ozempic and Wegovy: Study Flags Gastrointestinal Concerns
Discover the latest study findings revealing potential gastrointestinal risks associated with popular weight loss medications Ozempic and Wegovy. Learn about the study's implications for those considering these drugs for weight management
New Study Sheds Light on the Best Time to Exercise for Weight Management
Unlock the secret to successful weight management with insights from a recent report published in Obesity that delves into the science of circadian rhythms and their impact on maximizing weight loss through strategic exercise timing. Discover the ideal workout hours recommended by experts for effective weight management and a healthier lifestyle.